A pharmacy benefit manager facing upcoming trials over its role in the opioid crisis has moved to disqualify Motley Rice, citing alleged ethical violations tied to confidential information the law firm received through government subpoenas.
In a Friday motion, Alston & Bird’s Brian Boone, representing OptumRx Inc., referenced Motley Rice’s role as outside counsel for Hawaii, Chicago and the attorney general of the District of Columbia, all of which have investigated or sued the United HealthCare-owned pharmacy benefit manager.
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
